Metformin blocks HIF1α-phosphofructokinase (PFK), which catalyzes the third step of glycolysis, and lactate release in hepatoma cells and tumor tissues, thereby attenuating HCC growth [243]. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.